HRT Financial’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-40,200
Closed -$1.02M 3130
2022
Q3
$1.02M Buy
40,200
+14,600
+57% +$512K 0.01% 892
2022
Q2
$850K Sell
25,600
-22,000
-46% -$934K 0.01% 1056
2022
Q1
$3.43M Buy
47,600
+21,600
+83% +$1.56M 0.02% 407
2021
Q4
$2.39M Buy
26,000
+20,100
+341% +$2.4M 0.01% 569
2021
Q3
$748K Buy
+5,900
New +$859K ﹤0.01% 1589
2021
Q2
Sell
-36,100
Closed -$6.56M 3515
2021
Q1
$6.56M Buy
+36,100
New +$8.37M 0.07% 218

Other funds holding TDOC

HRT Financial's TDOC Position: Q4 2025 in Review

HRT Financial sold out of Teladoc Health (TDOC) in Q4 2025, closing a stake of 178,419 shares — an estimated $1.38M sold.

HRT Financial first reported a position in TDOC in Q3 2018 and held it in 12 quarters. The position peaked at $26.9M in Q2 2020. 345 funds tracked by Wall St. Rank hold TDOC as of Q4 2025.

  • HRT Financial reported no remaining Teladoc Health position as of Q4 2025 after selling out during the quarter.
  • HRT Financial sold 178,419 Teladoc Health shares in Q4 2025, an estimated $1.38M.
  • HRT Financial first reported a position in Teladoc Health in Q3 2018 and held it in 12 quarters.
  • HRT Financial's Teladoc Health position peaked at $26.9M in Q2 2020.
  • 345 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.